Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Scientists Use Microbes, Methane to Create Sustainable Omega 3

May 5, 2016 4:00 pm | by University of Nottingham | News | Comments

Scientists are trying to find new ways to produce the nutritional fatty acids.


Novel Disease Model Developed to Study Multiple Myeloma

May 5, 2016 3:00 pm | by University of Miami School of Medicine | News | Comments

Multiple myeloma affects more than 30,000 Americans each year and is slightly more prevalent in men than in women.


Gene Replacement Therapy Offers Viable Treatment Option for Fatal Disease

May 5, 2016 2:00 pm | by University of Missouri-Columbia | News | Comments

The therapy has the ability to cross the blood-brain barrier and directly targets motor neurons affected by SMARD1.


FDA Brings E-Cigarettes Under Federal Authority

May 5, 2016 1:00 pm | by Matthew Perrone, AP Health Writer | News | Comments

New federal rules announced Thursday have the potential to upend the multibillion-dollar electronic cigarette industry.


Timed-Release Glaucoma Drug Insert as Alternative to Daily Drops

May 5, 2016 9:40 am | by American Academy of Ophthalmology | News | Comments

A new device that slowly releases eye medication may one day be a promising option for the many glaucoma patients who struggle with administering their own daily prescription eye drops.


'Kidney on a Chip' Could Lead to Safer Drug Dosing

May 5, 2016 9:13 am | by University of Michigan | News | Comments

The new technique could lead to more precise dosing of drugs, including some potentially toxic medicines often delivered in intensive care units.


Starving Cancer The Key to New Treatments

May 5, 2016 9:08 am | by Australian National Laboratory | News | Comments

Researchers have identified a vital supply route that cancer cells use to obtain their nutrients.


Merck Beats 1Q Profit Views with Tight Cost Controls

May 5, 2016 9:04 am | by Linda A. Johnson, AP Business Writer | News | Comments

The second-biggest U.S. drugmaker on Thursday nudged up its 2016 financial forecasts and its shares edged up in premarket trading.


Effective New Drugs to Raise Heart Failure Market Value to $11.8B

May 5, 2016 8:37 am | by Elizabeth Hamson, Ph.D., Cardiovascular and Metabolic Disorders Analyst, GlobalData | Articles | Comments

Entresto has struggled to penetrate the chronic heart failure market, achieving dismal sales in the US since its launch in July 2015.


Takeda's Brintellix Renamed Trintellix

May 5, 2016 8:35 am | News | Comments

The formulation, indication and dosages of Trintellix remain the same as that of Brintellix.


FDA Warns Abilify Linked to Compulsive Urges

May 5, 2016 8:34 am | by Ryan Bushey, Digital Editor | Articles | Comments

The Food and Drug Administration issued a warning on Tuesday that reports of compulsive binge-eating, shopping, gambling, and sex have been connected to the antipsychotic Abilify.


Ketamine Lifts Depression Via Byproduct of its Metabolism

May 5, 2016 8:10 am | by National Institute of Health | News | Comments

Clinical trials by Zarate and others have shown that ketamine can lift depression in hours, or even minutes.


AstraZeneca Completes Acquisition of Takeda's Respiratory Business

May 5, 2016 8:00 am | News | Comments

AstraZeneca has marketed Daliresp in the US since the acquisition of the rights from Actavis in the first quarter of 2015.


CVS Health Tops Street 1Q Forecasts

May 5, 2016 7:30 am | by The Associated Press | News | Comments

Specialty drugs and retail expansions boosted CVS Health's first-quarter revenue by 18.9 percent, helping to offset higher costs and push results above Wall Street expectations.


Regeneron Pain Drug Clears Late-Stage Trial

May 4, 2016 4:00 pm | by Amrutha Penumudi, Reuters | News | Comments

The drug was tested on 421 patients with a history of inadequate pain relief or intolerance to current pain killers.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.